A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02

Clinical trial NCT03776539 · COMPLETED

Trial details

NCT number: NCT03776539
Sponsor: Eloxx Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Impaired Renal Function

Start date: 2019-01-04
Primary completion: 2019-07-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.